{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:20:55Z","timestamp":1790216455479,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.trim.2024.102054","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T01:51:28Z","timestamp":1715651488000},"page":"102054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Impact of donor-specific antibody with low mean fluorescence intensity on allograft outcomes in kidney transplant"],"prefix":"10.1016","volume":"84","author":[{"given":"Rungthiwa","family":"Kitpermkiat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surasak","family":"Kantachuvesiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sansanee","family":"Thotsiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duangtawan","family":"Thammanichanond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Rostaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punlop","family":"Wiwattanathum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.trim.2024.102054_bb0005","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellares","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.trim.2024.102054_bb0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/ndt\/gfy168","article-title":"Causes of renal allograft failure in the UK: trends in UK renal registry and National Health Service Blood and transplant data from 2000 to 2013","volume":"34","author":"Burton","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"issue":"7","key":"10.1016\/j.trim.2024.102054_bb0015","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1681\/ASN.2015070781","article-title":"Effect of immunosuppressive drugs on humoral Allosensitization after kidney transplant","volume":"27","author":"Thaunat","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2024.102054_bb0020","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3389\/fimmu.2016.00570","article-title":"Detection of HLA antibodies in organ transplant recipients - triumphs and challenges of the solid phase bead assay","volume":"7","author":"Tait","year":"2016","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.trim.2024.102054_bb0025","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/TP.0000000000001115","article-title":"The risk of transplant failure with HLA mismatch in first adult kidney allografts from deceased donors","volume":"100","author":"Williams","year":"2016","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.trim.2024.102054_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-1755.2005.00376.x","article-title":"Chronic renal allograft rejection: pathophysiologic considerations","volume":"68","author":"Joosten","year":"2005","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.trim.2024.102054_bb0035","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/TP.0000000000000149","article-title":"Tacrolimus trough level at discharge predicts acute rejection in moderately sensitized renal transplant recipients","volume":"97","author":"Richards","year":"2014","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.trim.2024.102054_bb0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00007890-199607270-00009","article-title":"Correlation of elisa-detected igg and iga anti-hla antibodies in pretransplant sera with renal allograft rejection1","volume":"62","author":"Kerman","year":"1996","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.trim.2024.102054_bb0045","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/tri.12533","article-title":"Pretransplant virtual PRA and long-term outcomes of kidney transplant recipients","volume":"28","author":"Huber","year":"2015","journal-title":"Transpl. Int."},{"issue":"5","key":"10.1016\/j.trim.2024.102054_bb0050","article-title":"The Pre-Transplant Drop in Panel-Reactive Antibodies Titer Evaluated Using Complement-Dependent Cytotoxicity (PRA-CDC) and the Risk of Early Acute Rejection in Sensitized Kidney Transplant Recipients","volume":"vol. 54","author":"Kolonko","year":"2018","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"10.1016\/j.trim.2024.102054_bb0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.trre.2014.11.001","article-title":"Monitoring T cell alloreactivity","volume":"29","author":"Mehrotra","year":"2015","journal-title":"Transplant. Rev."},{"issue":"4","key":"10.1016\/j.trim.2024.102054_bb0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/MOT.0b013e3283071463","article-title":"T-cell immune monitoring in organ transplantation","volume":"13","author":"Dinavahi","year":"2008","journal-title":"Curr. Opin. Organ Transplant."},{"issue":"4","key":"10.1016\/j.trim.2024.102054_bb0065","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/iid3.504","article-title":"Impact of low-level pretransplant donor-specific antibodies on outcomes after kidney transplantation","volume":"9","author":"Parajuli","year":"2021","journal-title":"Immun Inflamm Dis."},{"key":"10.1016\/j.trim.2024.102054_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2022.101672","article-title":"Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - a single-center experience","volume":"74","author":"Olszowska-Zaremba","year":"2022","journal-title":"Transpl. Immunol."},{"issue":"4","key":"10.1016\/j.trim.2024.102054_bb0075","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3343\/alm.2023.43.4.364","article-title":"Impact of low-level donor-specific anti-HLA antibody on Posttransplant clinical outcomes in kidney transplant recipients","volume":"43","author":"Lee","year":"2023","journal-title":"Ann. Lab. Med."},{"issue":"5","key":"10.1016\/j.trim.2024.102054_bb0080","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.trim.2024.102054_bb0085","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/01.TP.0000055833.65192.3B","article-title":"Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome","volume":"75","author":"Worthington","year":"2003","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.trim.2024.102054_bb0090","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1681\/ASN.2016070797","article-title":"Antibody-mediated rejection due to preexisting versus De novo donor-specific antibodies in kidney allograft recipients","volume":"28","author":"Aubert","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2024.102054_bb0095","doi-asserted-by":"crossref","first-page":"1265796","DOI":"10.3389\/fimmu.2023.1265796","article-title":"Complement-activating donor-specific anti-HLA antibodies in solid organ transplantation: systematic review, meta-analysis, and critical appraisal","volume":"14","author":"Al-Awadhi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2024.102054_bb0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.trim.2017.11.002","article-title":"Donor-specific HLA antibodies in predicting crossmatch outcome: comparison of three different laboratory techniques","volume":"46","author":"Perasaari","year":"2018","journal-title":"Transpl. Immunol."},{"issue":"1","key":"10.1016\/j.trim.2024.102054_bb0105","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13279","article-title":"Luminex crossmatch in kidney transplantation","volume":"98","author":"Ameur","year":"2023","journal-title":"Scand. J. Immunol."},{"issue":"19","key":"10.1016\/j.trim.2024.102054_bb0110","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa060068","article-title":"Rabbit antithymocyte globulin versus basiliximab in renal transplantation","volume":"355","author":"Brennan","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.trim.2024.102054_bb0115","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1681\/ASN.2008101037","article-title":"Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients","volume":"20","author":"Noel","year":"2009","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327424000704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327424000704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T02:55:34Z","timestamp":1716951334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327424000704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":23,"alternative-id":["S0966327424000704"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2024.102054","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of donor-specific antibody with low mean fluorescence intensity on allograft outcomes in kidney transplant","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2024.102054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102054"}}